MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ARYA, S. K.
Right arrow Articles by TS’O, P. O. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by ARYA, S. K.
Right arrow Articles by TS’O, P. O. P.

Molecular Pharmacology, Vol 11, 501-505, Copyright © 1975 by the American Society for Pharmacology and Experimental Therapeutics

Inhibition of Murine Leukemia Virus Replication in Cell Culture and Spleen Focus Formation in Mice by Polyadenylic Acids

S. K. ARYA 1, W. A. CARTER 1, J. L. ALDERFER 2, and P. O. P. TS’O 2

1 Department of Medical Viral Oncology, Roswell Park Memorial Institute, Buffalo, New York 14203
2 Department of Biochemical and Biophysical Sciences, School of Hygiene and Public Health, The Johns Hopkins University, Baltimore, Maryland 21205

Poly(adenylic acid), poly(2'-O-methyladenylic acid), and poly(2'-O-ethyladenylic acid) moderately inhibit the synthesis of Moloney murine leukemia virus in cultured JLS-V9 cells. Moreover, they are potent inhibitors of spleen focus formation by Friend murine leukemia virus in mice. Both in cell cultures and in the animal system, the order of inhibitory potency observed is poly(2'-O-ethyladenylic acid) > poly(2'-O-methyladenylic acid) > poly(adenylic acid). This order is identical with the one we have noted for inhibition of the RNA-directed DNA polymerases of these two viruses. While the molecular basis of inhibition of viral replication is not yet known, our results are compatible with the notion that RNA-directed DNA polymerase may he a drug target in vivo.

Note:
ACKNOWLEDGMENT We thank Dr. J. S. Horoszewicz for helpful discussions.

Submitted on December 23, 1974







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1975 by the American Society for Pharmacology and Experimental Therapeutics